A
14.59
0.68 (4.89%)
| Penutupan Terdahulu | 13.91 |
| Buka | 13.90 |
| Jumlah Dagangan | 1,693,738 |
| Purata Dagangan (3B) | 1,158,246 |
| Modal Pasaran | 1,622,208,384 |
| Harga / Jualan (P/S) | 0.660 |
| Harga / Buku (P/B) | 5.94 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2026 |
| Margin Operasi (TTM) | 16,317.06% |
| EPS Cair (TTM) | -3.10 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -99.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.69% |
| Nisbah Semasa (MRQ) | 12.05 |
| Aliran Tunai Operasi (OCF TTM) | -206.98 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -182.62 M |
| Pulangan Atas Aset (ROA TTM) | -40.72% |
| Pulangan Atas Ekuiti (ROE TTM) | -83.24% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Amylyx Pharmaceuticals, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.4
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.38 |
|
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 9.54% |
| % Dimiliki oleh Institusi | 85.89% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Saturn V Capital Management Lp | 31 Mar 2026 | 4,349,885 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |